Potential therapeutic uses for S-nitrosothiols

Clinical Science

Volumn 102, Issue 1, 2002, Pages 99-105

  Richardson, G ^a   Benjamin, N ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Drug therapy; Nitric oxide; Platelet; S nitrosoalbumin; Thiols

Indexed keywords

ALBUMIN; AMINO ACID; ASCORBIC ACID; CAPTOPRIL; COPPER; CYSTEINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROSO DERIVATIVE; POLYPEPTIDE; PROTEIN; S NITROSOALBUMIN; S NITROSOCYSTEINE; S NITROSOGLUTATHIONE; S NITROSOTHIOL DERIVATIVE; THIOL DERIVATIVE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID METABOLISM; ANTIMICROBIAL THERAPY; ANTIOXIDANT ACTIVITY; ASTHMA; BIOCHEMISTRY; BLOOD VESSEL TONE; COMMON COLD; DIAGNOSTIC VALUE; DRUG DEGRADATION; DRUG MECHANISM; DRUG STABILITY; GLUTATHIONE METABOLISM; HUMAN; INFECTION; MOLECULAR INTERACTION; PREDICTION; PRIORITY JOURNAL; REACTION ANALYSIS; REPERFUSION; REVIEW;

ANTI-ASTHMATIC AGENTS; ANTI-INFECTIVE AGENTS; DRUG INTERACTIONS; HUMANS; NITRIC OXIDE DONORS; PLATELET AGGREGATION INHIBITORS; S-NITROSOTHIOLS;

EID: 0036176869     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20010207     Document Type: Review

References (59)

1. Nitric oxide: Physiology, pathophysiology, and pharmacology
2. Clinical applications of nitric oxide
3. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin
4. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways
5. Chemiluminescence-based assay for S-nitrosoalbumin and other plasma S-nitrosothiols
6. The chemistry of S-nitrosothiols
7. S-Nitrosoglutathione as a substrate for γ-glutamyl transpeptidase
8. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols
9. Xanthine oxidase-mediated decomposition of S-nitrosothiols
10. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: Potential as a slow release nitric oxide donor drug
11. N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: Chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries
12. Glyco-S-nitrosothiols: Sugar-SNAP, a new type of nitric oxide donor
13. Dynamic state of S-nitrosothiols in human plasma and whole blood
14. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide
15. Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners
16. The potent inhibitory effects of S-nitrosated albumin coating of artificial surfaces
17. The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats
18. Dual role of S-nitrosocaptopril as an inhibitor of angiotensin-converting enzyme and a nitroso group carrier
19. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme
20. S-nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats: Role of the endothelium
21. Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Willebrand factor, AR545C: In vitro and ex vivo inhibition of platelet function
22. Prospects for therapy of nitrate tolerance
23. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure
24. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteries
25. S-nitroso-glutathione inhibits platelet activation in vitro and in vivo
26. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione
27. Effects of S-nitrosoglutathione in the human forearm circulation: Evidence for selective inhibition of platelet activation
28. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors
29. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty
30. S-nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo
31. A study of platelet activation during human cardiopulmonary bypass and the effect of S-nitrosoglutathione
32. S-nitrosoglutathione reduces the rate of embolization in humans
33. L-arginine and S-nitrosoglutathione reduce embolization in humans
34. Reversal of cerebral vasospasm by the nitric oxide donor SNAP in an experimental model of subarachnoid haemorrhage
35. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: Therapeutic potential in bypass surgery
36. The mechanism of cardioprotection by S-nitrosoglutathione monoethyl ester in rat isolated heart during cardioplegic ischaemic arrest
37. Protective effect of S-nitrosylated α(1)-protease inhibitor on hepatic ischemia-reperfusion injury
38. Treatment of HELLP syndrome with nitric oxide donor
39. The effects of S-nitrosoglutathione on platelet activation, hypertension and uterine and foetal Doppler in severe preeclampsia
40. Relaxation of human bronchial smooth muscle by S-nitrosothiols
41. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure
42. Albumin nitrosylated by activated macrophages posses antiparasitic effects neutralized by anti-NO-acetylated-cysteine antibodies
43. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium
44. Reversible S-nitrosation and inhibition of HIV-1 protease
45. Nitric oxide modulated HIV-1 replication
46. S-nitrosothiols as novel, reversible inhibitors of human rhinovirus 3C protease
47. Inhibition of sphincter of Oddi by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans
48. Modulation of T cell responses by nitric oxide and its derivative, S-nitrosoglutathione
49. Visible light photochemical release of nitric oxide from S-nitrosoglutathione: Potential photochemotherapeutic applications
50. S-transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide
51. Reaction of S-nitrosothiols with ascorbate: Clear evidence of two reactions
52. Biologic and pharmacologic regulation of mammalian glutathione synthesis
53. Decomposition of S-nitrosothiols: The effect of added thiols
54. Changes in the intracellular homocysteine and glutathione content associated with aging
55. Blood and plasma glutathione measured in healthy subjects by HPLC: Relation to sex, aging, biological variables, and life habits
56. Plasma glutathione concentration in patients with chronic hepatitis C virus infection
57. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome
58. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals
59. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients